Soc. Generale Knock-Out Encavis A.../ DE000SN8RM15 /
17/06/2024 12:16:07 | Var.+0.010 | Denaro17/06/2024 | Lettera- | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.660EUR | +1.54% | 0.660 Quantità in denaro: 15,000 |
- Quantità in lettera: - |
ENCAVIS AG INH. O.N... | 23.5056 EUR | 31/12/2078 | Put |
GlobeNewswire
12:04
Gilat to Acquire Stellar Blu, an IFC Market Leader with a First-to-Market ESA-Based Solution for Com...
GlobeNewswire
12:00
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-c...
GlobeNewswire
12:00
Keros Therapeutics Presents Clinical Data from its Elritercept (KER-050) Program at the 29th Annual ...
GlobeNewswire
12:00
Scott McGillivray Real Estate Trust II Joins addy Platform, Pioneering a New Era of Accessible Real ...
GlobeNewswire
12:00
Wawa’s Hoagiefest® is Back with $5 Shortis and $6 Classics and Four Additional Weeks of Savings! “Ke...
GlobeNewswire
12:00
Atomo Coffee Reveals Breakthrough Discovery to Instantly Slash Coffee-Related Deforestation, Urging ...
GlobeNewswire
12:00
Shoals Technologies Group to Launch Global Suite of Solutions at Intersolar Europe
GlobeNewswire
11:39
Correction: Amarna Therapeutics announces formation of Scientific Advisory Board to support advancem...
GlobeNewswire
11:23
Amarna Therapeutics announces formation of Scientific Advisory Board to support advancement of groun...
GlobeNewswire
10:20
Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immu...
Newsfile Corp
10:19
Shelf Gains Adaptation Among SMBs and Enterprises, Grows Double Digits in US and Canadian Market